ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析

◆英語タイトル:ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15899
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ImmunoGen Inc (IMGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of novel antibody-drug conjugates (ADCs) that facilitate targeted therapies for the treatment of cancer. The company is also advancing a new class of indolino-benzodiazepine deoxy ribonucleic acid (DNA)-acting payload agents, namely IGNs. It is investigating its lead product candidate, mirvetuximab soravtansine in Phase 3 clinical trials; and combination of bevacizumab and pembrolizumab in Phase 2 clinical studies for the treatment of platinum-resistant ovarian cancer. ImmunoGen is investigating IMGN779 in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632 for the treatment of AML, and blastic plasmacytoid dendritic cell neoplasm (BPDCN). ImmunoGen is headquartered in Waltham, Massachusetts, the US.

ImmunoGen Inc Key Recent Developments

Mar 01,2019 http://investor.immunogen.com/news-releases/news-release-details/immunogen-announces-top-line-results-phase-3-forward-i-study
Mar 01,2019 ImmunoGen Announces TopLine Results from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer
Mar 01,2019 ImmunoGen struck by Phase III trial failure in ovarian cancer
Feb 27,2019 ImmunoGen announces multiple presentations at AACR Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ImmunoGen Inc – Key Facts
ImmunoGen Inc – Key Employees
ImmunoGen Inc – Key Employee Biographies
ImmunoGen Inc – Major Products and Services
ImmunoGen Inc – History
ImmunoGen Inc – Company Statement
ImmunoGen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ImmunoGen Inc – Business Description
R&D Overview
ImmunoGen Inc – Corporate Strategy
ImmunoGen Inc – SWOT Analysis
SWOT Analysis – Overview
ImmunoGen Inc – Strengths
ImmunoGen Inc – Weaknesses
ImmunoGen Inc – Opportunities
ImmunoGen Inc – Threats
ImmunoGen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ImmunoGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2019: http://investor.immunogen.com/news-releases/news-release-details/immunogen-announces-top-line-results-phase-3-forward-i-study
Mar 01, 2019: ImmunoGen Announces TopLine Results from Phase 3 FORWARD I Study of Mirvetuximab Soravtansine in Ovarian Cancer
Mar 01, 2019: ImmunoGen struck by Phase III trial failure in ovarian cancer
Feb 27, 2019: ImmunoGen announces multiple presentations at AACR Annual Meeting
Feb 08, 2019: ImmunoGen reports recent progress and 2018 operating results
Jan 09, 2019: NIIMBL Announces New Projects to Advance Biopharmaceutical Manufacturing
Nov 26, 2018: ImmunoGen announces resignation of Chief Financial Officer
Nov 26, 2018: ImmunoGen announces resignation of chief financial officer
Nov 02, 2018: ImmunoGen reports recent progress and third quarter 2018 operating results
Oct 20, 2018: ImmunoGen Presents Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018 Congress
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ImmunoGen Inc, Key Facts
ImmunoGen Inc, Key Employees
ImmunoGen Inc, Key Employee Biographies
ImmunoGen Inc, Major Products and Services
ImmunoGen Inc, History
ImmunoGen Inc, Subsidiaries
ImmunoGen Inc, Key Competitors
ImmunoGen Inc, Ratios based on current share price
ImmunoGen Inc, Annual Ratios
ImmunoGen Inc, Annual Ratios (Cont...1)
ImmunoGen Inc, Interim Ratios
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
ImmunoGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ImmunoGen Inc, Performance Chart (2014 - 2018)
ImmunoGen Inc, Ratio Charts
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
ImmunoGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caja de Ahorros de Salamanca y Soria:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Caja de Ahorros de Salamanca y …
  • DiscoveRx Corporation(製薬・医療分野):企業M&A動向
    Summary DiscoveRx Corporation (DiscoveRx) is a pharmaceutical and healthcare company. It focuses on the development, manufacture, and commercialization of solutions that are used for discovery research. The products that the company offers include cell lines, assay ready kits, biochemical & 2nd mess …
  • SpineGuard, S.A. (ALSGD):企業財務及び戦略的SWOT分析
    Summary SpineGuard, S.A. (SpineGuard) is a medical device company that designs, develops and markets spine surgery products. The company offers PediGuard, a device that detects possible vertebral cortex perforation during pedicle preparation for screw placement and alerts the surgeon prior to a brea …
  • Jacada Ltd. (JCDAF):企業概要、財務及び戦略的SWOT分析
    Summary Jacada Ltd. (Jacada) is a software solution provider. The company provides desktops and process optimization software solutions to its clients. Its contact center products include Jacada workspace agent desktop, Jacada agent scripting and Jacada UI for CRM. Jacada provides mobile self servic …
  • Veridex, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Veridex, LLC Mergers and Acquis …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):企業財務及び戦略的SWOT分析
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that provides isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It offers radiation therapy products for Brachytherapy, a minimally invasive pro …
  • Boise Cascade Company (BCC):企業財務及び戦略的SWOT分析
    Summary Boise Cascade Company (Boise Cascade) is a building products provider that manufactures and supplies wood products and building materials for various customers. The company offers products such as plywood, lumber, particleboard, and a broad line of building materials. Its building materials …
  • La Plata Electric Association, Inc.:発電所・企業SWOT分析
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Grunenthal GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Grunenthal GmbH (Grunenthal) is a research-oriented pharmaceutical company. It researches, develops, produces and markets products for the treatment of pain and innovative formulations of established active substances. The company provides new chemical entities including opioids for moderate …
  • Housing Development Finance Corporation Ltd:企業の戦略・SWOT・財務情報
    Housing Development Finance Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Housing Development Finance Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Southwest Airlines Co.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Southwest Airlines Co. Mergers …
  • Athera Biotechnologies AB(製薬・医療分野):企業M&A動向
    Summary Athera Biotechnologies AB (Athera) is a biopharmaceutical company. It develops targeted anti inflammatory biological candidate drugs and companion diagnostics for the prevention and treatment of cardiovascular disease. The company has a proprietary pre IND program, PC-mAb, supported by an ap …
  • Mercury Industries Berhad (MERCURY):企業の財務及び戦略的SWOT分析
    Summary Mercury Industries Berhad (Mercury Industries) is a chemical company that manufactures, trades, markets, and distributes paints and related products. The company offers products which include poly, putty, primers, clears and auto paints, among others. It also offers products such as sandpape …
  • Eagle Oil & Gas Co.(石油・ガス分野):企業M&A動向
    Summary Eagle Oil & Gas Co. (Eagle Oil) is an oil and gas company. The company acquires, develops, drills, engineers, regulates, and explores oil and gas reserves. It provides contract drilling services. Eagle Oil's projects include state line stack, eagle ford shale, Haynesville, Oklahoma stack, we …
  • Bio-Rad Laboratories Inc (BIO)-医療機器分野:企業M&A・提携分析
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops and manufactures specialty chemicals for use in biochemical, pharmaceutical and other life science research applications. The company offers a comprehensive range of reagents, apparatus, laboratory instruments, test systems, informatics systems, te …
  • Eau Technologies, Inc. (EAUI):企業の財務及び戦略的SWOT分析
    Summary Eau Technologies, Inc. (Eau Tech) is a healthcare technology company that develops, manufactures and markets electrolyzed oxidative and reductive water equipment for business applications. The company offers products which include empowered water generators, primacide A, primacide B and prim …
  • Core-Mark Holding Company, Inc.:企業の戦略・SWOT・財務分析
    SummaryCore-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Alesi Surgical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Alesi Surgical Ltd (Alesi Surgical), formerly Asalus Medical Instruments Ltd, is a medical device company that develops and markets laparoscopic surgical smoke handling systems. The company offers Ultravision, a system that removes laparoscopic surgical smoke without the need for gas exchang …
  • Okoworld AG (VVV3):企業財務及び戦略的SWOT分析
    Summary Okoworld AG (OKOWORLD), formerly Versiko AG, is a financial service firm that provides insurance brokering, financial advising and asset managing services. The company’s product portfolio include pension, life and disability insurances; inuilding society savings; private health insurance and …
  • MicuRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. Its lead produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆